‘In China, for China’ is something we have lived by in the past three decades, and this is evident in our actions, not just our words
In Conversation
We have seen a huge growth in the numbers of clients from Asia. These are extremely sophisticated biotech companies coming from countries like China and South…
We hope Asieris can bridge [China and the US] and synergize all their advantages to build an outstanding company with great products
I realized that if I wanted to establish a global biotech company in Shanghai, I should look to work with Chinese companies since they would be…
Our ambition is to use technology to expand the capacity of the healthcare system to serve patient needs. Our solutions have already been deployed across more…
Our ultimate vision and dream is to empower elderly people to have longer, healthier and happier lives at home.
An exclusive interview with Jason Smith, SVP (Asia Pacific, Middle East and Africa); Gerry Muhle, VP (International Medical Aesthetics); and White Wang, China President, of Allergan,…
Today, we consider ourselves the pioneers of what we have called the contract development and commercialization organization (CDCO)
Our vision is really quite unique because we are mentoring and supporting these companies from the very beginning of their journey, when they are in desperate…
We combined US experience and Chinese infrastructure to accelerate the entire drug discovery process.
In the past few years, we have seen a changing awareness of healthcare needs in China. The government has launched significant reforms because they are looking…
At McKinsey, we bring in a more holistic understanding of the ecosystem and help our clients solve intellectually and operationally complex problems in order to deliver…
